Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Loading…
2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting
Rapoport, Bernardo Leon, Herrstedt, Jørn, Snow, Rebecca Clark, Radhakrishnan, Venkatraman, Saito, Mitsue, Navari, Rudolph M., Smit, Teresa
Published in Supportive care in cancer (01.01.2024)
Published in Supportive care in cancer (01.01.2024)
Get full text
Journal Article
Loading…
2016 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following multiple-day chemotherapy, high-dose chemotherapy, and breakthrough nausea and vomiting
Einhorn, Lawrence H., Rapoport, Bernardo, Navari, Rudolph M., Herrstedt, Jørn, Brames, Mary J.
Published in Supportive care in cancer (01.01.2017)
Published in Supportive care in cancer (01.01.2017)
Get full text
Journal Article
Loading…
Effects of 5-mg dose of olanzapine for breakthrough nausea and vomiting in patients receiving carboplatin-based chemotherapy: a prospective trial
Maeda, Akimitsu, Yoshida, Hiroki, Inoue, Hirotaka, Ejiri, Masayuki, Yamaguchi, Satoe, Kushihara, Hideyuki, Yamamoto, Yoshihiro, Ando, Yosuke, Sato, Yumiko, Tashiro, Yuusuke, Hasegawa, Ayako, Takahara, Yuko, Mizutani, Mika, Oze, Isao, Shimizu, Junichi
Published in Annals of Palliative Medicine (01.03.2021)
Published in Annals of Palliative Medicine (01.03.2021)
Get full text
Journal Article
Loading…
Evaluation of Antiemetic Therapy for Breakthrough Nausea and Vomiting in Patients with Hematopoietic Stem Cell Transplantation
Kim, Jiyoon, Hong, So Yeon, Jeon, Su Jeong, Namgung, Hyung Wook, Lee, Eun Sook, Lee, Euni, Bang, Soo-Mee
Published in Korean Journal of Clinical Pharmacy (30.09.2018)
Published in Korean Journal of Clinical Pharmacy (30.09.2018)
Get full text
Journal Article
Loading…
Prevalence of breakthrough chemotherapy-induced nausea vomiting in patients on highly emetogenic chemotherapy: A Single-center observational study
Lokkur, Pooja, Mahanta, Neelakshi, Kalita, Naba, Deka, Hitesh, Kutum, Niharika, Ray, Arpita
Published in Oncology Journal of India (01.09.2021)
Published in Oncology Journal of India (01.09.2021)
Get full text
Journal Article
Loading…
Antiemetics: American Society of Clinical Oncology Clinical Practice Guideline Update
Hesketh, Paul J., Kris, Mark G., Basch, Ethan, Bohlke, Kari, Barbour, Sally Y., Clark-Snow, Rebecca Anne, Danso, Michael A., Dennis, Kristopher, Dupuis, L. Lee, Dusetzina, Stacie B., Eng, Cathy, Feyer, Petra C., Jordan, Karin, Noonan, Kimberly, Sparacio, Dee, Somerfield, Mark R., Lyman, Gary H.
Published in Journal of clinical oncology (01.10.2017)
Published in Journal of clinical oncology (01.10.2017)
Get full text
Journal Article
Loading…
Treatment of breakthrough and prevention of refractory chemotherapy‐induced nausea and vomiting in pediatric cancer patients: Clinical practice guideline update
Patel, Priya, Robinson, Paula D., Phillips, Robert, Baggott, Christina, Devine, Katie, Gibson, Paul, Guilcher, Gregory M. T., Holdsworth, Mark T., Neumann, Eloise, Orsey, Andrea D., Spinelli, Daniela, Thackray, Jennifer, Wetering, Marianne, Cabral, Sandra, Sung, Lillian, Dupuis, L. Lee
Published in Pediatric blood & cancer (01.08.2023)
Published in Pediatric blood & cancer (01.08.2023)
Get full text
Journal Article
Loading…
Guideline for the Treatment of Breakthrough and the Prevention of Refractory Chemotherapy-Induced Nausea and Vomiting in Children With Cancer
Flank, Jacqueline, Robinson, Paula D., Holdsworth, Mark, Phillips, Robert, Portwine, Carol, Gibson, Paul, Maan, Cathy, Stefin, Nancy, Sung, Lillian, Dupuis, L. Lee
Published in Pediatric blood & cancer (01.07.2016)
Published in Pediatric blood & cancer (01.07.2016)
Get full text
Journal Article
Loading…
The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy
Navari, Rudolph M., Nagy, Cindy K., Gray, Sarah E.
Published in Supportive care in cancer (01.06.2013)
Published in Supportive care in cancer (01.06.2013)
Get full text
Journal Article
Loading…
Loading…
Assessing duration of breakthrough chemotherapy-induced nausea and vomiting (CINV): A pooled study analysis of NEPA versus aprepitant
Navari, Rudolph M., Binder, Gary, Bonizzoni, Erminio, Clark-Snow, Rebecca, Olivari Tilola, Silvia, Roeland, Eric
Published in Journal of clinical oncology (20.05.2021)
Published in Journal of clinical oncology (20.05.2021)
Get full text
Journal Article
Loading…
Comparison of vestipitant with ondansetron for the treatment of breakthrough postoperative nausea and vomiting after failed prophylaxis with ondansetron
Kranke, P., Thompson, J.P., Dalby, P.L., Eberhart, L.H., Novikova, E., Johnson, B.M., Russ, S.F., Noble, R., Brigandi, R.A.
Published in British journal of anaesthesia : BJA (01.03.2015)
Published in British journal of anaesthesia : BJA (01.03.2015)
Get full text
Journal Article
Loading…
Loading…
Breakthrough chemotherapy-induced nausea and vomiting: report of a nationwide survey by the CINV Study Group of Japan
Tamura, Kazuo, Aiba, Keisuke, Saeki, Toshiaki, Nakanishi, Yoichi, Kamura, Toshiharu, Baba, Hideo, Yoshida, Kazuhiro, Yamamoto, Nobuyuki, Kitagawa, Yuko, Maehara, Yoshihiko, Shimokawa, Mototsugu, Hirata, Koichi, Kitajima, Masaki
Published in International journal of clinical oncology (01.04.2017)
Published in International journal of clinical oncology (01.04.2017)
Get full text
Journal Article
Loading…
A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation
Nakagaki, Midori, Barras, Michael, Curley, Cameron, Butler, Jason P., Kennedy, Glen A.
Published in Supportive care in cancer (01.02.2017)
Published in Supportive care in cancer (01.02.2017)
Get full text
Journal Article
Loading…
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Uchiike, Akihiro, Kono, Haruka, Miura, Katsuhiro, Hayama, Tatsuya, Tsutsumi, Daisuke, Tsuboi, Shinya, Ohtsuka, Susumu, Hidaka, Shinji
Published in Journal of pharmaceutical health care and sciences (01.08.2023)
Published in Journal of pharmaceutical health care and sciences (01.08.2023)
Get full text
Journal Article
Loading…
Olanzapine treatment effectively relieves breakthrough chemotherapy-induced nausea and vomiting: a real-world experience
Akihiro Uchiike, Haruka Kono, Katsuhiro Miura, Tatsuya Hayama, Daisuke Tsutsumi, Shinya Tsuboi, Susumu Ohtsuka, Shinji Hidaka
Published in Journal of Pharmaceutical Health Care and Sciences (01.08.2023)
Published in Journal of Pharmaceutical Health Care and Sciences (01.08.2023)
Get full text
Journal Article
Loading…
Aprepitant for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy
Inoue, Takako, Kimura, Madoka, Uchida, Junji, Nishino, Kazumi, Kumagai, Toru, Taniguchi, Junko, Imamura, Fumio
Published in International Journal of Clinical Oncology (01.06.2017)
Published in International Journal of Clinical Oncology (01.06.2017)
Get full text
Journal Article
Loading…
Abstract PS13-09: Chemotherapy-induced nausea and vomiting (CINV) risk after prior breakthrough CINV: Unmasking the false average
Navari, Rudolph M, Binder, Gary, Molassiotis, Alexander, Roeland, Eric, Ruddy, Kathryn J., LeBlanc, Thomas W., Kloth, Dwight D., Sebastiani, Silvia, Dimberg, Lina Y., Schmerold, Luke M., Liu, Xing, Schwartzberg, Lee
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Published in Cancer research (Chicago, Ill.) (15.02.2021)
Get full text
Journal Article